Your browser doesn't support javascript.
loading
Prediction model for drug response of acute myeloid leukemia patients.
Trac, Quang Thinh; Pawitan, Yudi; Mou, Tian; Erkers, Tom; Östling, Päivi; Bohlin, Anna; Österroos, Albin; Vesterlund, Mattias; Jafari, Rozbeh; Siavelis, Ioannis; Bäckvall, Helena; Kiviluoto, Santeri; Orre, Lukas M; Rantalainen, Mattias; Lehtiö, Janne; Lehmann, Sören; Kallioniemi, Olli; Vu, Trung Nghia.
Afiliação
  • Trac QT; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Pawitan Y; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Mou T; School of Biomedical Engineering, Shenzhen University, Shenzhen, China.
  • Erkers T; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Östling P; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Bohlin A; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Österroos A; Department of Medicine Huddinge, Karolinska Institutet, Unit for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Vesterlund M; Department of Medical Sciences, Hematology, Uppsala University Hospital, Uppsala, Sweden.
  • Jafari R; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Siavelis I; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Bäckvall H; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Kiviluoto S; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Orre LM; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Rantalainen M; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Lehtiö J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Lehmann S; Department of Oncology Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Kallioniemi O; Department of Medicine Huddinge, Karolinska Institutet, Unit for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Vu TN; Department of Medical Sciences, Hematology, Uppsala University Hospital, Uppsala, Sweden.
NPJ Precis Oncol ; 7(1): 32, 2023 Mar 24.
Article em En | MEDLINE | ID: mdl-36964195
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia